Analyst Moves in as Tandem Diabetes Care Tests 200-Day

TNDM stock will need to break out above the $75 price point

Oct 18, 2019 at 10:01 AM
facebook twitter linkedin

Tandem Diabetes Care Inc (NASDAQ:TNDM) has essentially been moving sideways on the charts since February, trading in a tight range around the $60 level with the $55 region serving as support during a few brief pullbacks. This treading has let the closely watched 200-day moving average catch up to the shares, and it's served as a notable floor in the past three sessions following Tuesday's news of a team-up with Abbott Laboratories (ABT). What's more, an analyst just came in and recommended for investors to pick up the stock.

Specifically, Guggenheim began coverage with a "buy" rating and $76 price target, which is notable since the $75 price point has been a stiff ceiling during the equity's multi-month sideways trend. In fact, it's been three years since Tandem Diabetes Care has topped the $75 mark, though the average analyst price target actually rests up at $79.75. Analysts definitely like the stock, since 80% of those in coverage were recommending to buy the shares already.

Options traders have been bullish, as well. The 10-day call/put volume ratio at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is 4.69 and ranks in the 81st annual percentile, showing stronger-than-normal demand for long calls. Peak open interest sits at the November 65 call, and the November 70 call is also home to a large number of contracts. TNDM shares are giving bulls hope today at least, last seen trading 2.1% higher after Guggenheim's note, putting them at $64.47.


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Best stocks for October and worst stocks for October


Special Offers from Schaeffer's Trading Partners